MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastomaSarah E. Woodfield(The University of Texas MD Anderson Cancer Center), Sanjeev A. Vasudevan(Baylor College of Medicine)Scientific ReportsFebruary 3, 202110.1038/s41598-021-82542-4Cited by 41SaveCiteExport RISWatch citationsRelated PapersDe-Regulation of JNK and JAK/STAT Signaling in ESCRT-II Mutant Tissues Cooperatively Contributes to Neoplastic Tumorigenesis|PLoS ONE|2013|28